From the magazine

It’s a typical evening in a Canadian community pharmacy. As you finalize the last prescriptions of the day, your attention shifts to a familiar sight—a solitary soul navigating the OTC aisle, eyes scanning the shelves in quiet desperation.

Patients using icodec tend to have a higher incidence of hypoglycemic events compared to glargine or degludec, especially on days 2–4 of the weekly dosing cycle.